The Lancet
Results, published in "The Lancet" medical journal, of the WOMAN (World Maternal Antifibrinolytic) international study that began in 2010, finds use of a cheap and widely available drug, tranexamic acid (Lysteda in the U.S. and Australia), could save the lives of thousands of women who die in childbirth from excessive bleeding. The medication is already in use for blood loss from major trauma, surgery, tooth removal, nose bleeds, and heavy menstruation.
Sources: The Guardian The New York Times